{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:53:08Z","timestamp":1790142788771,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["L248025"],"award-info":[{"award-number":["L248025"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jpba.2026.117507","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T17:01:42Z","timestamp":1776013302000},"page":"117507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Identification of anticancer and cardioprotective quality markers in Chuanxiong Rhizoma using a bioassay driven effect-constituent index approach"],"prefix":"10.1016","volume":"277","author":[{"given":"Jiahui","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuya","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5767-5127","authenticated-orcid":false,"given":"Chunyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpba.2026.117507_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s40364-024-00631-8","article-title":"Global burden of breast cancer and attributable risk factors in 204 countries and territories, from 1990 to 2021: results from the global burden of disease study 2021","volume":"12","author":"Sha","year":"2024","journal-title":"Biomark. Res."},{"issue":"1","key":"10.1016\/j.jpba.2026.117507_bib2","first-page":"47","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J. Natl. Cancer Cent."},{"issue":"34","key":"10.1016\/j.jpba.2026.117507_bib3","doi-asserted-by":"crossref","first-page":"5700","DOI":"10.1200\/JCO.2009.23.2025","article-title":"High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller","volume":"27","author":"Gonzalez-Angulo","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.jpba.2026.117507_bib4","first-page":"1045","article-title":"The trastuzumab era: current and upcoming targeted HER2+ breast cancer therapies","volume":"10","author":"Kreutzfeldt","year":"2020","journal-title":"Am. J. Cancer Res."},{"issue":"12","key":"10.1016\/j.jpba.2026.117507_bib5","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1056\/NEJMoa2115022","article-title":"Trastuzumab deruxtecan versus trastuzumab emtansine for breast cancer","volume":"386","author":"Cort\u00e9s","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpba.2026.117507_bib6","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.103953.3","article-title":"Targeting SLC7A11-mediated cysteine metabolism for the treatment of trastuzumab-resistant HER2-positive breast cancer","volume":"14","author":"Hua","year":"2025","journal-title":"eLife"},{"issue":"16","key":"10.1016\/j.jpba.2026.117507_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14163996","article-title":"Overcoming resistance to HER2-directed therapies in breast Cancer","volume":"14","author":"Schlam","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.jpba.2026.117507_bib8","first-page":"22","article-title":"Mechanisms of trastuzumab induced cardiotoxicity - is exercise a potential treatment?","volume":"9","author":"Eaton","year":"2023","journal-title":"Cardiooncology"},{"issue":"1","key":"10.1016\/j.jpba.2026.117507_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10549-021-06280-x","article-title":"Trastuzumab-induced cardiotoxicity: a review of clinical risk factors, pharmacologic prevention, and cardiotoxicity of other HER2-directed therapies","volume":"188","author":"Dempsey","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jpba.2026.117507_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1479983","article-title":"Interventions for prevention and treatment of trastuzumab-induced cardiotoxicity: an umbrella review of systematic reviews and meta-analyses","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Pharm."},{"issue":"24","key":"10.1016\/j.jpba.2026.117507_bib11","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1016\/j.jacc.2017.04.041","article-title":"Traditional Chinese medicine for cardiovascular disease: evidence and potential mechanisms","volume":"69","author":"Hao","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.jpba.2026.117507_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13020-021-00539-7","article-title":"Traditional Chinese Medicine for adjuvant treatment of breast cancer: Taohong Siwu Decoction","volume":"16","author":"Jiang","year":"2021","journal-title":"Chin. Med."},{"key":"10.1016\/j.jpba.2026.117507_bib13","article-title":"Ligusticum Chuanxiong: a chemical, pharmacological and clinical review","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Pharm."},{"key":"10.1016\/j.jpba.2026.117507_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fpls.2024.1463666","article-title":"Application of metabolomics in quality control of traditional Chinese medicines: a review","volume":"15","author":"Ji","year":"2024","journal-title":"Front. Plant Sci."},{"issue":"2","key":"10.1016\/j.jpba.2026.117507_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jpha.2020.11.008","article-title":"Development of chromatographic technologies for the quality control of Traditional Chinese medicine in the Chinese pharmacopoeia","volume":"11","author":"Shen","year":"2021","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jpba.2026.117507_bib16","article-title":"Editorial: bioassays for assessing traditional medicines: promises and pitfalls","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Pharm."},{"key":"10.1016\/j.jpba.2026.117507_bib17","article-title":"Ligusticum Chuanxiong: a chemical, pharmacological and clinical review","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Pharm."},{"issue":"3","key":"10.1016\/j.jpba.2026.117507_bib18","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1039\/D1FO02811A","article-title":"A comprehensive investigation on the chemical diversity and efficacy of different parts of Ligusticum Chuanxiong","volume":"13","author":"Yan","year":"2022","journal-title":"Food Funct."},{"issue":"9","key":"10.1016\/j.jpba.2026.117507_bib19","doi-asserted-by":"crossref","first-page":"10614","DOI":"10.3390\/molecules170910614","article-title":"Advances in the chemical analysis and biological activities of Chuanxiong","volume":"17","author":"Li","year":"2012","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.jpba.2026.117507_bib20","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/pca.3498","article-title":"HPTLC-bioautography-MS-guided strategy for the detection of phthalides with antimicrobial and antioxidant activities from Ligusticum Chuanxiong essential oil","volume":"36","author":"Wang","year":"2025","journal-title":"Phytochem. Anal."},{"key":"10.1016\/j.jpba.2026.117507_bib21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.phymed.2018.03.013","article-title":"Promotion of quality standard of Chinese herbal medicine by the integrated and efficacy-oriented quality marker of Effect-constituent Index","volume":"45","author":"Xiong","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jpba.2026.117507_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115455","article-title":"Improving Chuanxiong Rhizoma quality standards using an effect-constituent index based bioassay","volume":"233","author":"Li","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"11","key":"10.1016\/j.jpba.2026.117507_bib23","doi-asserted-by":"crossref","first-page":"17897","DOI":"10.3390\/molecules191117897","article-title":"Spectrum-effect relationships as a systematic approach to traditional chinese medicine research: current status and future perspectives","volume":"19","author":"Xu","year":"2014","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.jpba.2026.117507_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ph17091157","article-title":"Evaluation of the pharmaceutical activities of Chuanxiong, a key medicinal material in traditional Chinese medicine","volume":"17","author":"Huang","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.jpba.2026.117507_bib25","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1038\/s41598-017-02305-y","article-title":"A bioactive chemical markers based strategy for quality assessment of botanical drugs: xuesaitong Injection as a Case Study","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpba.2026.117507_bib26","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.phymed.2018.02.009","article-title":"The method of quality marker research and quality evaluation of traditional Chinese medicine based on drug properties and effect characteristics","volume":"44","author":"Zhang","year":"2018","journal-title":"Phytomedicine"},{"issue":"8","key":"10.1016\/j.jpba.2026.117507_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28083636","article-title":"Senkyunolide I: a review of its phytochemistry, pharmacology, pharmacokinetics, and drug-likeness","volume":"28","author":"Huang","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.jpba.2026.117507_bib28","article-title":"The protective effects and potential mechanisms of Ligusticum Chuanxiong: focus on anti-inflammatory, antioxidant, and antiapoptotic activities, evid.-based complement","volume":"2020","author":"Shi","year":"2020","journal-title":"Altern. Med."},{"issue":"12","key":"10.1016\/j.jpba.2026.117507_bib29","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000041841","article-title":"Mechanistic insights into the anticancer effects of Pinellia ternata (Thunb.) Ten. ex Breitenb. and Ligusticum Chuanxiong Hort. ex S. H. Qiu & al. on papillary thyroid carcinoma: a network pharmacology approach","volume":"104","author":"Wang","year":"2025","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.jpba.2026.117507_bib30","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/s41467-021-21841-w","article-title":"mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.jpba.2026.117507_bib31","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1073\/pnas.1821022116","article-title":"Ferroptosis as a target for protection against cardiomyopathy","volume":"116","author":"Fang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jpba.2026.117507_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115455","article-title":"Improving Chuanxiong Rhizoma quality standards using an effect-constituent index based bioassay","volume":"233","author":"Li","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117507_bib33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.phymed.2018.01.016","article-title":"Quality markers based on biological activity: a new strategy for the quality control of traditional Chinese medicine","volume":"44","author":"Wu","year":"2018","journal-title":"Phytomedicine"},{"issue":"23","key":"10.1016\/j.jpba.2026.117507_bib34","first-page":"6264","article-title":"Application of bioassay in quality evaluation of Chinese medicine: a review","volume":"47","author":"Zhang","year":"2022","journal-title":"China J. Chin. Mater. Med."},{"issue":"2","key":"10.1016\/j.jpba.2026.117507_bib35","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1021\/acs.jnatprod.9b00949","article-title":"Scientific and regulatory approach to botanical drug development: a U.S. FDA perspective","volume":"83","author":"Wu","year":"2020","journal-title":"J. Nat. Prod."}],"updated-by":[{"DOI":"10.1016\/j.jpba.2026.117613","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T00:00:00Z","timestamp":1794700800000}}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526001755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526001755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:15:55Z","timestamp":1783455355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708526001755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":35,"alternative-id":["S0731708526001755"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117507","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of anticancer and cardioprotective quality markers in Chuanxiong Rhizoma using a bioassay driven effect-constituent index approach","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117507","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117507"}}